Heidelberg University Hospital

Heidelberg University Hospital (UKHD) is one of Europe’s leading university hospitals, renowned for its advanced patient care, cutting-edge research, and academic excellence. It fosters interdisciplinary collaboration and drives innovation across 50 medical departments, spanning a wide range of clinical and research fields. More than 13,500 employees share the ultimate goal of improving patients’ lives.
Within UKHD, the Department of Diagnostic and Interventional Radiology (DIR) fosters a collaborative environment that unites scientists from diverse fields and medical professionals. Key focus areas include lung and cardiovascular imaging, abdominal imaging and interventional radiology, musculoskeletal imaging, oncologic imaging, and pediatric imaging, with additional expertise in computational image analysis and medical physics. These efforts, supported by major funding agencies such as BMBF, DFG, and the EU, emphasize translating research findings into tangible clinical benefits. The DIR participates in multiple national and international collaborations, including SOLACE, DZL/TLRC, NAKO, RACOON, PERMED COPD, and LYSIM CANCER, and has most recently joined the EUCAIM consortium.

Role of institution in the project

UKHD is involved in Work Package 7 as a use-case. In its role as a Data User, it will further train and validate an AI-based algorithm that uses deep-learning segmentation and radiomics-based “virtual biopsies” for the detection and assessment of advanced-stage non-small cell lung cancer (NSCLC).

Prof. Dr. med. Hans-Ulrich Kauczor

Prof. Dr. med. Hans-Ulrich Kauczor has been Full Professor and Chairman of Radiology at Heidelberg University Hospital since 2008, also serving as Medical Director of Diagnostic and Interventional Radiology. Since 2018, he leads the Translational Lung Research Center Heidelberg and sits on the Board of Directors at the German Center of Lung Research. His primary research focuses on structural and functional thoracic radiology, utilizing CT and MRI, which have led to the development of innovative, world-renowned diagnostic methods for lung and tumor diseases.

Dr. Bettina Katalin Budai

Dr. Bettina Katalin Budai is a postdoctoral researcher at DIR UKHD leading a newly forming interdisciplinary research group focused on the development of deep learning-based image analysis tools to support automated assessment targeting a diverse range of pathologies in the context of body imaging. She holds an MD, and a PhD degree in Clinical Science from Semmelweis University, Hungary, with a specialization in artificial intelligence and radiomics analysis in abdominal imaging. In 2024, she was awarded a fellowship in the Medical Data Scientist Program at the Medical Faculty of the University of Heidelberg with the aim of identifying prognostic imaging biomarkers in colorectal cancer patients.

Join the EUCAIM Consortium

Open Call for New Beneficiaries

We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.

Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.

Apply by 10 June 2024!

Find out more

Open Call Webinar

We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.

WATCH THE RECORDING

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

Sign up for more information

SAVE THE DATE
March 14, 10:00-11:30 aM CET

DISCOVER THE CANCER IMAGE EUROPE PLATFORM

TECHNICAL DEMONSTRATION WEBINAR

Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.

Participate